Cobalt(II,III) oxide: Difference between revisions
Jump to navigation
Jump to search
imported>Paul Derry No edit summary |
mNo edit summary |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
== Summary == | == Summary == | ||
| Line 18: | Line 20: | ||
== Health Issues == | == Health Issues == | ||
RTECS recognizes Cobalt(II,III) oxide as a tumorigen in oral LD50 trials with lethal doses of greater than 5g/kg per day in rats. This is characteristic with other oxides of cobalt | |||
<!-- References | <!-- References | ||
| Line 23: | Line 28: | ||
1. http://digitalfire.com/gerstleyborate/material/m-01b121.htm | 1. http://digitalfire.com/gerstleyborate/material/m-01b121.htm | ||
--> | -->[[Category:Suggestion Bot Tag]] | ||
[[Category: | |||
Latest revision as of 06:00, 30 July 2024
Summary
Cobalt(II,III) oxide is the most prevalent of cobalt's various oxides. The oxide is typically found in ores alongside containing nickel, arsenic, sulfur, and manganese. These ores can be found in great quantities in Canada, Southern Africa, and Morocco among other locales.
This oxide has a gunmetal gray appearance and is typically distributed in a powdered form.
Derivative Compounds
Reactions of Cobalt(II,III) oxide can yield other oxides with similar characteristics:
When heated in the presence of excess oxygen:
- Co3O4(s) + O2(g) → 3 Co2O3(s)
The reaction yields Cobalt(III) Oxide.
Industrial Uses
Health Issues
RTECS recognizes Cobalt(II,III) oxide as a tumorigen in oral LD50 trials with lethal doses of greater than 5g/kg per day in rats. This is characteristic with other oxides of cobalt